San Diego, CA, USA January 22, 2025 – Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets and develop small molecule precision therapeutics for devastating cancers and immune disorders, today announced the promotion of Jean Bemis to Chief Operating Officer. Ms. Bemis is an accomplished biotech leader […] The post Vividion Therapeutics Announces Promotion of Jean Bemis to Chie...
